RhumbLine Advisers’s InfuSystem Holdings INFU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,157
Closed -$86.9K 4195
2025
Q1
$86.9K Buy
16,157
+546
+3% +$3.99K ﹤0.01% 3437
2024
Q4
$132K Sell
15,611
-1,163
-7% -$9.17K ﹤0.01% 3389
2024
Q3
$112K Sell
16,774
-884
-5% -$5.73K ﹤0.01% 3467
2024
Q2
$121K Buy
17,658
+2,145
+14% +$15.8K ﹤0.01% 3460
2024
Q1
$133K Buy
15,513
+836
+6% +$7.85K ﹤0.01% 3351
2023
Q4
$155K Sell
14,677
-232
-2% -$2.28K ﹤0.01% 3300
2023
Q3
$144K Buy
14,909
+963
+7% +$9.86K ﹤0.01% 3329
2023
Q2
$134K Buy
+13,946
New +$126K ﹤0.01% 3414
2022
Q2
Sell
-16,232
Closed -$159K 3166
2022
Q1
$159K Buy
16,232
+5,021
+45% +$64.5K ﹤0.01% 2804
2021
Q4
$191K Sell
11,211
-319
-3% -$5.06K ﹤0.01% 2844
2021
Q3
$150K Buy
11,530
+825
+8% +$13.5K ﹤0.01% 2949
2021
Q2
$223K Buy
10,705
+478
+5% +$9.66K ﹤0.01% 2894
2021
Q1
$208K Sell
10,227
-580
-5% -$10.9K ﹤0.01% 2822
2020
Q4
$203K Buy
+10,807
New +$163K ﹤0.01% 2832
2020
Q3
Sell
-11,732
Closed -$135K 3005
2020
Q2
$135K Buy
+11,732
New +$135K ﹤0.01% 2895

Other funds holding INFU

RhumbLine Advisers's INFU Position: Q2 2025 in Review

RhumbLine Advisers sold out of InfuSystem Holdings (INFU) in Q2 2025, closing a stake of 16,157 shares — an estimated $86.9K sold.

RhumbLine Advisers first reported a position in INFU in Q2 2020 and held it in 15 quarters. The position peaked at $223K in Q2 2021. 93 funds tracked by Wall St. Rank hold INFU as of Q2 2025.

  • RhumbLine Advisers reported no remaining InfuSystem Holdings position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 16,157 InfuSystem Holdings shares in Q2 2025, an estimated $86.9K.
  • RhumbLine Advisers first reported a position in InfuSystem Holdings in Q2 2020 and held it in 15 quarters.
  • RhumbLine Advisers's InfuSystem Holdings position peaked at $223K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.